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Abstract
Introduction: We describe the use of a ablating system to compartmentalise and regionally 
isolate the atria in paroxysmal and persistent atrial fibrillation (AF).                          
Methods:  40 patients were studied, 25 paroxysmal AF and 14 persistent AF. One patient 
enrolled was later found to be in left atrial flutter and was excluded. The Cardima Revelation® 
TX catheter system with Intellitemp® Radiofrequency (RF) energy control device and a 
Medtronic Atakar® RF generator were used to place wide area circumferential ablations to 
achieve conduction block into the left and right sided pulmonary veins. Roof lines and mitral 
isthmus lines were also performed. In patients with persistent AF and in repeat procedures, 
right atrial compartmentalisation was performed with an anterior superior vena cava (SVC) to 
inferior vena cava (IVC) line and a septal SVC to IVC line.                                   
Results: At 6 months, 18 of the 39 patients were asymptomatic, 10 had improved symptoms 
and 22 were in sinus rhythm. In the paroxysmal group, 11 were asymptomatic, 7 had improved 
symptoms and 16 (64%) were in sinus rhythm.  In the persistent group, 7 were asymptomatic, 
3 had improved symptoms and 6 (43%) were in sinus rhythm. The total group AF burden was 
37.8 ± 5.4 hrs pre-procedure and 23.1 ±5.1 hrs at 6 months post procedure. Mean temperature, 
impedance and power recorded at each pole demonstrated effective power delivery at all poles. 
No catheter charring was observed, complication rates were comparable to standard AF 
ablation   technique.                                                                        
Conclusion: Linear ablation in the left and right atria to mimic Cox's Maze is feasible and safe 
using this ablating system.                                                                                             
Keywords: Atrial fibrillation, linear ablation, catheter performance, clinical outcome             
            
Introduction
Paroxysmal atrial fibrillation (AF) is frequently initiated by triggers in the pulmonary veins.  
Pulmonary vein isolation (PVI) can eliminate the AF triggers from entering the left atrium and 
prevent occurrence of AF [1]. Linear ablation theoretically creates "lines of block" which 
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disperse the refractory periods hence reducing the capability of atrium to sustain AF [2]. 
Surgically deployed intra-operative linear atrial lines, as in Cox's Maze operation[3] are highly 
effective in reducing the occurrence of AF even in patients in very diseased atria [4,5]. This 
has led to the presumption that the same success can be achieved with catheter based 
techniques, however these attempts have met with variable success [6]. Procedure times are 
long and it can be difficult to ascertain whether an ablation line is complete. Even if a line 
appears complete at the time of the procedure, gaps can appear in the subsequent healing 
process leading to recurrent arrhythmia. Incomplete linear lesions can be pro-arrhythmic and 
predispose to new arrhythmias, in particular left atrial flutter [7]. Investigators reported 
improved ablation success rates by the addition of linear lines to the PVI procedure, in 
particular the mitral isthmus line [8] and the left atrial roof line [9]. A recent evaluation of the 
efficacy of LA linear ablation using a hexapolar linear multi-electrode mapping/ablation 
catheter has described safety and acute outcomes [10]. In this study, we propose to assess 
safety and 6 month clinical outcome following PVI and linear ablation using a multi-electrode 
ablation catheter to create continuous linear lines in the left and right atria. This study is a 
preliminary report of the use of the Cardima Revelation T-flex ablating system® for this 
purpose. The approach is similar to the Cox Surgical Maze, but is less invasive, therefore 
carrying a lower risk of complication and a shorter recovery time.                         
Catheter ablation system – description                                                                     
i) Linear ablation catheter (Revelation T-flex ®)                                                                         
The Revelation T-flex® linear ablation catheter is a single use deflectable multi-electrode 
electrophysiology   catheter   designed   to   record   intracardiac   potentials   and   deliver 
radiofrequency energy for cardiac tissue ablation. The catheter has a linear configuration and is 
deflectable in one plane (Figure 1a), measuring 150cm in length with electrode spacing of 
2mm. The shaft has 16 signal recording electrodes and 16 ablation coils, each 3mm in length, 
with dual thermocouples at each electrode. The flexible coiled electrodes are integrated into 
the catheter and create deep continuous curvilinear transmural lesions. The thin lesions result 
in   less   surrounding   myocardial   tissue   damage.   Thermocouples   are   integrated   between 
electrodes to sense tissue temperature and sensing occurs through the coils. The catheter has a 
single plane of deflection and RF energy can be delivered through up to 8 electrodes 
simultaneously. The catheter has an atraumatic platinum tip coil for added safety. The catheter 
dimensions are: outer diameter 5.5 French, working length 130cm, curve reach 4cm, electrode 
length 3mm. In comparison to standard "drag and burn" ablation technologies, simultaneous 
ablation through multiple electrodes of a linear ablation catheter may shorten procedure time, 
in theory creating lesions that have penetrating depth without gaps along the linear trajectory. 
Figure  1a: Image of the Cardima Revelation T-flex Linear Ablation Catheter depicting its curve reach sheath
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ii) Deflectable guiding catheter/sheath (Naviport ®)                                                               
The Naviport torqueable support sheath can be used with the Revelation ablation catheter to 
provide additional support deflectability and maneuverability. It has a radiopaque shaft with a 
soft atraumatic tip. (Figure 1b).
Figure 1b: Image of the Cardima Naviport steerable sheath
 
iii) Energy Management Device (Intellitemp®)                                                                         
The Intellitemp® Energy Management Device (EMD) is used in conjunction with the 
Revelation ablation catheter to control the delivery of radio-frequency (RF) energy during 
ablation. RF energy can be applied at individual electrodes or in a combination of up to 8 
electrodes simultaneously (the proximal or distal set of the 16 electrodes or any combination of 
eight electrodes). Thermocouples provide direct temperature feedback from the tissue to the 
EMD which modulates the RF energy to each individual electrode based on the recorded 
temperature in order to create optimal lesion formation.  The feedback system incorporates 
impedance in addition to temperature and impedance out of set limits will result in that pole 
being switched off during energy application.                                                                               
This study was performed to assess several outcomes. Firstly to study the feasibility of creating 
linear ablation lines in the left and right atria using the Revelation T-flex catheter ablating 
system and to perform an evaluation of the catheter performance, assessing RF energy delivery 
and temperatures achieved. The second aim was to assess the practical use of the system in 
routine clinical workflow by evaluation of procedural and screening times.                        
Next, outcome evaluation of both acute ablation success with this system and clinical follow-
up data at 3 and 6 months post catheter ablation of symptoms, rate of recurrence of AF and AF 
burden. The final objective was to document the safety of this ablating catheter system.
Methods
Study   patients                                                                    
This prospective study was commenced following formal approval by the local hospital ethics 
committee. 40 consecutive patients with paroxysmal or persistent AF were enrolled for the 
study after informed written consent had been obtained. All patients enrolled into the study had 
documented symptomatic paroxysmal or persistent atrial fibrillation (AF) whilst taking one or 
more anti-arrhythmic medications.  AF was defined as persistent if present for > 7 days or a 
DC  cardioversion  attempt  had failed.                                                                   
These patients in AF had associated recognizable symptoms such as shortness of breath, 
palpitations, lightheadedness or fatigue.  'Refractory' AF was defined as a failed rhythm control 
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after trial of two or more anti-arrhythmic drugs (AAD) or Amiodarone alone. AAD failure was 
defined as the occurrence of AF after taking AADs for at least one month. In all patients the 
AAD regimen had to be stable without changes in the regimen/dosage in the previous month.  
The following exclusion criteria were applied - asymptomatic AF patients, patients unable to 
take formal anticoagulation therapy pre/post procedure or the presence of a left atrial clot seen 
on pre-procedure trans-oesophageal echocardiogram.                                                             
Patient symptoms and AF burden                                                                                                   
In each patient symptoms were documented and AF burden measured by 72 hour Holter 
monitoring (Getemed GE) at three clinic visits; before the procedure, three months and six 
months post procedure. Holter recordings were analysed using a Cardioday software system 
(GE version 11.0 for windows) with visual verification.                                                       
Ablation procedure protocol                                                                                                 
Two trans-septal punctures were performed to access the left atrium and angiograms of the left 
and right sided pulmonary veins were taken with contrast injection. Through the trans-septal 
sheaths an Optima Inquiry® catheter (St Jude Medical) and the T-flex ablation catheter, were 
deployed in the left atrium (Figure 2 a-d). Left atrial geometry was created using the NavX 
system (Ensite/St Jude) with a 6 French screw in reference catheter positioned in the right 
atrium as a geometry reference. The activated clotting time was maintained between 250 and 
300 sec with intravenous heparin throughout the procedure.
Figure 2 a): Ablation catheter position during WACA of the left pulmonary veins (LAO projection)
Figure 2 b):  Ablation catheter position during WACA of the right pulmonary veins (AP projection)
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Figure 2 c):   Ablation catheter placement during Left Atrial Roofline
Figure 2 d): Ablation catheter position during right atrial linear ablation
The Revelation T-flex ablation catheter with the Intellitemp energy management device and 
Medtronic Atakar radiofrequency generator were used to deliver radiofrequency ablation. The 
settings for energy delivery were temperature set at 50°C for 60-90 seconds with an impedance 
range of 190 to 247 ohms. Wide area circumferential ablations were performed to achieve 
conduction block into the left and right sided pulmonary veins, confirmed by the absence of 
significant signals within each vein post ablation. The Optima Inquiry® catheter (St Jude 
Medical) was used pre and post ablation to confirm successful pulmonary vein isolation. 
Coronary sinus pacing was also undertaken where necessary for confirmation of block.  
Independent pulmonary vein potentials in the absence of atrial capture confirmed pulmonary 
vein isolation. Linear ablation lines were next drawn along the roof between the left and right 
superior   veins   and   from   the   left   lower   pulmonary   vein   to  the   mitral   valve   annulus. 
Confirmation of block across the two ablation lines was not performed. Additionally, in 
patients with persistent atrial fibrillation or redo procedures, right atrial compartmentalisation 
with an anterior SVC-IVC line and septal SVC-IVC line was performed. Confirmation of 
block across the right atrial lines was not attempted. However, in this department we have 
previously   performed   right   atrial   linear   ablation   for   compartmentalisation,   confirming 
conduction block after ablation by pacing on either side of the line and following the 
conduction wavefront with an Ensite array® (St Jude) deployed in the right atrium. The 
ablation   catheter   performance   was   assessed   in   the   first   29   patients   studied.   Catheter 
temperature (°C), power (Watts) and impedance (Ohms) were recorded at each pole for each 
application, with mean values then calculated per pole and per patient.                         
Follow-up
Two follow-up visits were performed, at three and six months post procedure. Patients 
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remained on their previous anti-arrhythmic medication for at least 3 months after the ablation 
procedure and those in stable sinus rhythm after 6 months had anti-arrhythmic medication 
discontinued or reduced as appropriate. Anticoagulation post procedure was continued with 
warfarin.  
Data   Analysis                                                                                  
Categorical variables are expressed as frequencies and percentages. Continuous data are 
presented as mean value ± standard deviation (SD) or median. Continuous variables were 
analysed with the student's T-test and a value of less than 0.05 was considered statistically 
significant.
Results
The study was carried out at St Thomas Hospital between Jan 2007 and Jan 2009 and all 39 
patients completed 6 months of follow up.                                                       
Patient   characteristics                                                                                    
39 patients, 27 male were studied and underwent an ablation procedure.  The mean patient age 
was 60.8 years (range 39 - 77 yrs), mean duration of AF 7.5±0.9 years and average LA size 
4.2±1.0 cm. At enrolment 25 patients had paroxysmal AF and 14 had persistent AF. 12 patients 
had undergone a previous pulmonary vein isolation procedure. One patient enrolled was found 
subsequently at electrophysiological study to have left atrial flutter and was not included 
further in the study. Patient characteristics including number of previous AADs failed are 
shown in Table 1.
Table 1: Patient characteristics
* Hypertension, diabetes mellitus, mitral valvular heart disease, heart failure
Acute ablation success                                                                      
All 4 major pulmonary veins were isolated in all but one patient in whom it was not possible to 
isolate the right lower pulmonary vein.                                                                                   
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Patient  symptoms                                                                                            
In the total group 18 of the 39 patients were asymptomatic at 6 months, 10 had reduced 
symptoms and 11 remained symptomatic. The corresponding figures for paroxysmal and 
persistent AF are shown in Table 2. This demonstrates that more than 70% of patients in both 
paroxysmal and persistent AF reported an improvement in their symptoms. Interestingly, 50% 
of the persistent AF group were asymptomatic compared to 44% in the paroxysmal AF group. 
Table 2: Patient symptoms and mean AF burden at 0, 3 and 6 months
N= number of patients. AF burden = hours in AF during 72 hour Holter. Sinus rhythm = sinus rhythm throughout 
72 hour Holter. Students paired t-test was used to determine statistical significance.
AF burden, anti-arrhythmics and sinus rhythm at follow up                            
The number of patients in sinus rhythm at 3 and 6 months in the paroxysmal and persistent 
groups and the AF burden from the Holter data are also shown in Table 2. At 6 months, 18 of 
the 39 patients were asymptomatic, 10 had improved symptoms and 22 were in sinus rhythm. 
In the paroxysmal group, 11 were asymptomatic, 7 had improved symptoms and 16 (64%) 
were in sinus rhythm.   In the persistent group, 7 were asymptomatic, 3 had improved 
symptoms and 6 (43%) were in sinus rhythm. At 6 months, all 16 PAF patients who were in 
sinus rhythm came off anti-arrhythmics whilst those with recurrences (9 patients) were 
maintained on their baseline medication: 7 patients on Beta-blockers, 5 on flecainide and 2 on 
calcium channel blockers (4 with one anti-arrhythmic and 5 on two   anti-arrhythmics). 3 
patients came off amiodarone.  In the persistent AF group, 9 patients came off amiodarone 
whilst the others were maintained on their baseline anti-arrhythmics:  12 on beta-blockers, 3 on 
amiodarone, 2 on calcium channel blockers and 2 on digoxin (4 on a single anti-arrhythmic, 3 
with two anti-arrhythmics and 3 on three  anti-arrhythmics). There was a significant reduction 
in AF burden in the persistent AF group at 6 months (P<0.01) with 43% of this group holding 
sinus rhythm throughout the 3 day holter. Two patients had gap related atrial flutter on their 3 
month Holter monitor. All patients with recurrences were listed for a re-do procedure.  
Procedural times and catheter performance data                                                           
The mean procedural time was 217 ± 12 minutes with a mean fluoroscopy time of 37 ± 2 
minutes. The average number of RF applications per patient was 52 (range 12 to 90).  
Dichotomising procedural times into paroxysmal and persistent AF groups, the values are 
206±15 minutes and 248±10 minutes respectively.                                                                     
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 12 (3): 82-92 (2012)Arujuna A, “A Linear Ablating System in the Left and Right Atrium”                                 88
The mean catheter temperature, impedance and watts achieved in the first 29 study patients are 
shown in Figure 3. The mean temperature achieved was 49.9±0.4 °C, mean power delivered 
was 11.9±0.3 W and mean impedance encountered 227.7±8.5 ohms. A tabulated recording of 
this similar means achieved at each of the 16 catheter poles for the same study patients are 
presented in Table 3.
Figure 3: Ablation catheter temperature, power and impedance - mean values in the first twenty nine study 
patients. Means ± SEM - Power=11.9±0.3W, Temperature=49.9±0.4 °C, Impedance=227.7±8.5 ohms               
Complications  and  safety                                                                                    
No direct complication related to the catheter was observed. Two patients developed acute back 
burns, attributed to incorrectly sized back pads. After this problem was identified correct back 
pads were used in all subsequent cases and no further burns were observed. 2 patients had 
cardiac tamponade requiring pericardiocentesis. 2 patients developed gap related left atrial 
flutter  requiring catheter ablation. A third patient has developed  left atrial flutter after 
completion of the study period. No patient suffered a transient ischemic attack or stroke. 
Catheter charring was not observed during any of the procedures.                          
Discussion
AF burden/Clinical outcome/Symptoms                                                                       
In this study the AF burden was found to be significantly reduced for the total study and 
persistent AF groups following linear ablation. Although statistically non significant there was 
also a reduction in AF burden at 6 months in the paroxysmal group. Out of 39 patients, only 
three patients had a higher AF burden post than pre procedure.  Of particular note is that almost 
half the persistent AF patients, all of whom were in AF pre-procedure, were holding sinus 
rhythm at 6 months after a single procedure. Interestingly in our study cohort, persistent patients 
who failed the ablation procedure universally returned to AF and none converted from persistent 
to paroxysmal AF.
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Table 3: Ablation catheter temperature, power and impedance per each of the 16 poles in the 
first 29 study patients
Data = mean ± SEM
The proportion of patients in the paroxysmal group demonstrating improved symptoms was 
greater than in the persistent group. However the reduction in AF burden on Holter was not as 
high   as   expected   given   this   improvement   in   symptoms.   Explanations   for   symptomatic 
improvement despite continuing AF could include ganglionic plexus modification or placebo 
effect.  
Catheter   performance                                                                              
The presented data suggests that the Cardima Revelation linear ablation catheter system can be 
used to achieve acute pulmonary vein isolation. Conduction block into the pulmonary veins is 
strongly suggestive of effective lesion application and this end point which was convincingly 
demonstrated in all but one patient. The energy delivered at each pole of the catheter during the 
60 to 90 second applications appears to be sufficient to achieve effective tissue destruction at the 
respective application site. Indeed split potentials and diminished electrograms demonstrable in 
some but not all cases suggesting an adequate lesion depth has been achieved at each pole. The 
Intellitemp system was documented to deliver sufficient energy at up to 8 catheter poles at a 
time. The Intellitemp automatically notes if a pole goes out of range for temperature, power or 
impedance and appropriately responds for each ablation point, ie if impedance becomes high it 
will switch off power to that pole. This is indicated on the output of the device allowing for 
further ablation to be performed  again if necessary. The power delivered at the poles of the 
ablation catheter were generally much lower than single pole ablation. Two reasons behind this 
include firstly temperature was limited to 50 degrees to avoid excessive overheating and 
potential charring. Secondly, the generator was limited to 100W such that on multiple poles 
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limited power was delivered although in general target temperatures were not always achieved. 
This suggests that a generator capable of delivering more RF energy than the 100W delivered 
through the Medtronic Atakar may be more effective. For this study, given this being the first 
clinical setting in utilising the catheter and for safety reasons, a more conservative lower power 
delivery was employed.  Future evaluation of cautious up-titration of power delivery would be 
needed. The target temperature and power  settings in this study was the same for each pole and 
similar settings were used   for PV isolation and all lines (including roof lines). Catheter 
manipulation can be difficult in some cases due to its longer length and may explain why the 
procedural times observed were not shorter than conventional burn and drag techniques in our 
laboratory. Manipulation of this catheter might be improved with operator experience following 
the learning curve and with the use of a steerable sheath (Cardima Naviport ®).                 
Acute   results                                                                                
In this study the pulmonary veins were isolated in all but one case. The right lower pulmonary 
vein was the most difficult to isolate. This was on some occasion undertaken using the tip of the 
catheter (poles 1 and 2) to deliver directed local lesions. In some cases the catheter structure 
became   distorted,   but   removal   of   catheter   with   manual   reshaping   was   feasible.   Linear 
application in the right atrium was easier to perform than in the left atrium and placement of the 
right sided lesions took less than 20 minutes. In terms of procedural time, this linear ablation 
catheter technique was comparable to previous data using standard ablation catheters/ablation 
techniques. The procedural time in the persistent patients with the addition of a RA MAZE was 
not longer than in those with PAF. This may be because in many of the persistent patients there 
was not much signal in the pulmonary veins at the start, with most of the procedure then directed 
towards bi-atrial compartmentalisation. The addition of a RA MAZE only added on average 20 
mins to the total procedure time.                                                                                           
Safety  
The catheter proved to be safe in this study as evident by no embolic complications. The lack of 
charring of the catheter may partly explain this observation. This study demonstrates that the 
catheter can be used safely in the left atrium. Using the correct back pads is necessary with this 
catheter   given   the   significant   energy   delivered   through   them.   Smaller   back   pads   were 
inadvertently   placed   for   procedures   on   2   patients   resulting   in   superficial   back   burns. 
Subsequently in every case two back plates were used and no further burns occurred. The rates 
of tamponade and of LA flutter were similar to those described with conventional techniques (2-
4%) [11,12]. Whilst no odynophagia and formal oesophageal injury was reported, an evaluation 
for potential injury was not performed. The current standard during RF ablation for AF utilizes 
irrigated tip catheters. The absence of irrigation in this catheter did not result in any subsequent 
clinical diagnosis of thrombo-embolic events  although no formal evaluation of cerebral blood 
flow was performed.                                                                                                       
Study   Limitations                                                                    
The main limitation of this study was that not all ablation lines were checked and block 
confirmed by pacing techniques. In determining post procedure AF burden, study patients were 
only monitored for 72 hours. 24 to 72 hours of monitoring of Holter monitoring has been 
recommended by the HRS/ACC/ESC societies for monitoring AF burden in the follow up of 
subjects in AF ablation trials, as documented in their 2007 consensus statement on AF catheter 
ablation [13]. However it is quite possible that AF occurs outside this 'snapshot' time period and 
an implanted loop recorder would be useful for accurate follow up of AF burden for a more 
clinically relevant longer and continuous time period. Also longer term follow-up would be 
useful to evaluate post-ablation atrial tachycardia occurrence.                                 
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Conclusion
In our initial experience, use of this linear ablating system within the left and right atrium to 
mimic Cox's MAZE procedure is feasible and safe. Further developments of this catheter and 
technique may reduce procedure times and increase therapeutic efficacy. A larger randomized 
study should be performed to evaluate the efficacy of this linear ablating system in assessing 
clinical   outcomes.                                                                                        
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